Abstract:Abstract Cystathionine β-synthase (CBS)-deficient patients are prone to vascular thrombosis. In contrast, Cbs −/− mice show no abnormalities in blood coagulation. To identify molecular basis underlying these disparately different thrombotic phenotypes, we analyzed plasma proteomes of Cbs −/− vs. Cbs +/+ mice (8-month-old, 12/group, sex-matched) and CBS −/− vs. CBS +/+ humans (37 ± 7-year-old, 10–14/group, sex-matched) using label-free mass spectrometry. We identified 117 and 41 differentiating plasma proteins in Cbs −/− mice and CBS −/− humans, respectively. Twenty-one proteins were shared between CBS −/− humans and Cbs −/− mice, with sixteen changed in the opposite direction. Proteins involved in blood coagulation and complement/coagulation cascades represented a greater fraction of the differentiating proteins in CBS −/− patients (51%) than in Cbs −/− mice (21%). Top canonical pathways, identified by Ingenuity Pathways Analysis, such as LXR/RXR, FXR/RXR activation (− log[ P -value] = 30–31) and atherosclerosis signaling (− log[ P -value] = 10–11) were similarly affected in Cbs −/− mice and CBS −/− humans. The Coagulation System was affected stronger in CBS −/− humans than in Cbs −/− mice (− log[ P -value] = 15 vs. 10, respectively) while acute phase response and complement system were affected stronger in Cbs −/− mice (− log[ P -value] = 33 and 22, respectively) than in humans (− log[ P -value] = 22 and 6, respectively). Other pathways, including IL-7 signaling and B cell development were affected only in Cbs −/− mice. Taken together, our findings suggest that differences in these processes, in particular in the Coagulation System, could account for the thrombotic phenotype in CBS −/− patients and the absence of thrombosis in Cbs −/− mice. Overall, our findings suggest that Cbs −/− mice have a better adaptive response to protect from prothrombotic effects of hyperhomocysteinemia than CBS −/− humans.

Active cystathionine beta-synthase can be expressed in heme-free systems in the presence of metal-substituted porphyrins or a chemical chaperone

Chemical chaperone rescue of mutant human cystathionine β-synthase

Allosteric Control of Human Cystathionine Β-Synthase Activity by a Redox Active Disulfide Bond

Potential Pharmacological Chaperones for Cystathionine Beta-Synthase-Deficient Homocystinuria

Effect of the disease-causing R266K mutation on the heme and PLP environments of human cystathionine β-synthase

Impact of primary sequence changes on the self‐association properties of mammalian cystathionine beta‐synthase enzymes

Targeting Cystathionine Beta-Synthase Misfolding in Homocystinuria by Small Ligands: State of the Art and Future Directions

Mechanism of action and impact of thiol homeostasis on efficacy of an enzyme replacement therapy for classical homocystinuria

S-glutathionylation Enhances Human Cystathionine Β-Synthase Activity under Oxidative Stress Conditions.

Expression, Purification and Activity Assay of the Full-length and Truncated Human Cystathionine Β-Synthase

Cellular turnover and degradation of the most common missense cystathionine beta‐synthase variants causing homocystinuria

Cystathionine β-synthase (CBS) deficiency suppresses erythropoiesis by disrupting expression of heme biosynthetic enzymes and transporter

Genetic and Pharmacological Modulation of Cellular Proteostasis Leads to Partial Functional Rescue of Homocystinuria-Causing Cystathionine-Beta Synthase Variants

Expression,purification and identification of I278T-mutant human cystathionine βsynthase

Nitration-mediated Deficiency of Cystathionine Β-Synthase Activity Accelerates the Progression of Hyperhomocysteinemia.

Real-time detection of enzymatically formed hydrogen sulfide by pathogenic variants of cystathionine beta-synthase using hemoglobin I of Lucina pectinata as a biosensor

Production of the Neuromodulator H2S by Cystathionine Β-Synthase Via the Condensation of Cysteine and Homocysteine

A Pharmacological Probe Identifies Cystathionine Β-Synthase As a New Negative Regulator for Ferroptosis

Altered gene expression in liver from a murine model of hyperhomocysteinemia

Pathogenic Homocystinuria-Associated T236N Mutation Dramatically Alters the Biochemical Properties of Cystathionine Beta-Synthase Protein

Cystathionine β-synthase deficiency: different changes in proteomes of thrombosis-resistant Cbs−/− mice and thrombosis-prone CBS−/− humans